Neobutin Extended-Release Tablets (Trimebutine Maleate)

Adult dose

Take 1 tablet twice a day on an empty stomach

This medication contains lactose and should not be taken by individuals with genetic disorders that prevent lactose breakdown. Such disorders include galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption. Women in the early three months of pregnancy or those who are breastfeeding should be cautious when using this medication and it is preferable to avoid it if possible. Animal studies have shown no teratogenic effects, but safety during pregnancy has not been fully established. Rarely, symptoms such as fatigue, sensations of heat or cold, mild diarrhea, nausea, vomiting, constipation, dyspepsia, drowsiness, and slight dizziness may occur while taking this medication. It is important to consult a medical professional if these symptoms arise.

Mild side effects

• Fatigue
• sensations of heat or cold
• mild diarrhea
• nausea
• vomiting
• constipation
• digestive disturbances
• slight drowsiness
• mild dizziness

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius to preserve the medication's effectiveness and safety over time.

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 120 tablets/bottle